Unicycive Therapeutics In...

NASDAQ: UNCY · Real-Time Price · USD
4.83
0.20 (4.32%)
At close: Aug 15, 2025, 2:36 PM

Unicycive Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a 675K 951K n/a
Cost of Revenue
428K n/a 7K 1K
Gross Profit
n/a 675K 944K -1K
Operating Income
-32.12M -20.77M -18.05M -8.98M
Interest Income
1.26M 615K n/a 628K
Pretax Income
-37.82M -30.54M -18.06M -10.02M
Net Income
-36.73M -30.54M -18.06M -10.63M
Selling & General & Admin
12.1M 8.55M 6.57M 2.9M
Research & Development
20.01M 12.9M 12.44M 6.08M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
32.12M 21.45M 19M 8.98M
Interest Expense
71K 82K 6K 628K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
-32.12M 21.45M 19M 8.98M
Income Tax Expense
-1.09M n/a 6K 615K
Shares Outstanding (Basic)
66.99M 2.45M 1.51M 1.5M
Shares Outstanding (Diluted)
66.99M 2.45M 1.51M 1.5M
EPS (Basic)
-0.06 -1.28 -1.2 -0.71
EPS (Diluted)
-0.06 -1.28 -1.2 -0.71
EBITDA
-36.23M -30.18M -18.05M -8.98M
EBIT
-37.9M -30.46M -18.05M -8.98M
Depreciation & Amortization
428K 284K 7K 1K